# Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation

> **NCT06171906** · PHASE4 · NOT_YET_RECRUITING · sponsor: **ShiCang Yu** · enrollment: 68 (estimated)

## Conditions studied

- MSC

## Interventions

- **BIOLOGICAL:** mesenchymal stromal cells

## Key facts

- **NCT ID:** NCT06171906
- **Lead sponsor:** ShiCang Yu
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2025-10-01
- **Final completion:** 2028-11-01
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2023-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06171906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06171906, "Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06171906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*